Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

vestments (1,299,844) (10,240,605)

Maturity of short-term

investments 8,125,034 17,661,017

Leasehold inducements - -

Long-term investment - -

Acquisition of facilities

and equipment (61,346) (517,554)

Disposal of equipment - -

---------------------------------------------------------

6,763,844 6,902,858

Increase in cash & cash

equivalents 2,907,759 3,344,044

Cash & cash equivalents,

beginning of period 5,635,365 4,077,065

-----------------------------------------------------------

Cash & cash equivalents,

end of period 8,543,124 7,421,109

-----------------------------------------------------------

-----------------------------------------------------------

-------------------------------------------------------------------------

Cumulative

Three-month Three-month since

period ended period ended inception on

May 31, May 31, August 11,

2008 2007 1999

$ $ $

-------------------------------------------------------------------------

Cash provided by (used in):

Operating activities:

Loss for the period (3,816,937) (3,036,132) (38,934,651)

Items not involving cash:

Amortization of:

Facilities and equipment 94,993 85,064 1,466,178

Defe
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... (PRWEB) May 29, 2015 Market ... (Chem-Report ) signed a partnership agreement for quality ... authorised to distribute and sell research reports worked ... at Partners Department, commented upon the agreement: “Chem-Report ... on key petroleum and chemical markets on global ...
(Date:5/29/2015)... , May 29, 2015  Caris Life ... two studies in which researchers utilized Caris Molecular ... to identify potential therapeutic targets in patients with ... of the programmed cell death protein 1 (PD-1) ... June 1 at the 2015 American Society of ...
(Date:5/29/2015)... TRIANGLE PARK, N.C. , May 29, 2015 ... Roger Jeffs , Ph.D., President and Co-Chief Executive Officer ... the company,s business at the Jefferies 2015 Global Healthcare Conference ... The presentation and the immediately following Q&A session will take ... Time, and can be accessed via a live webcast on ...
(Date:5/29/2015)... Translation is frequently listed as one of the ... used in a way that is right for a company, ... product or service offering. , Here are some of ... on a company's bottom line: , 1.    Attract bigger audience. , ... can use, why not offer it globally? Nelson Mandela once ...
Breaking Biology Technology:Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4Three Ways Translation Can Help Businesses Grow 2
... Inc. today,announced it anticipates receiving up to $65 ... was led by Alta Partners and Clarus Ventures ... High Country Venture., "This Series B round ... the,addition of two world class investor groups, Alta ...
... 1 Cardium Therapeutics (Amex:,CXM) announced that ... direct,offering with institutional and other accredited or ... 31, 2008. Empire Asset Management,Company acted as ... (Logo: http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ), The ...
... Pharmaceuticals,Inc. (Nasdaq: CADX ), a biopharmaceutical ... product candidates principally,for use in the hospital ... CEO Theodore Schroeder will present the corporate ... pm Eastern Time (1:00 pm Pacific Time),during ...
Cached Biology Technology:Taligen Therapeutics Secures Series B Financing 2Cardium Completes $5.3 Million Registered Direct Offering 2Cardium Completes $5.3 Million Registered Direct Offering 3Cardium Completes $5.3 Million Registered Direct Offering 4Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York 2
(Date:4/20/2015)... 2015 Huntington Memorial Hospital is the first ... new miniaturized, wireless monitoring sensor to manage heart failure ... only FDA-approved heart failure monitoring device that has been ... physicians to manage heart failure. The CardioMEMS ... the pulmonary artery (PA) during a non-surgical procedure to ...
(Date:4/17/2015)... Canada , April 17, 2015 ... growing security concerns, and technological advancement to drive ... until 2020   According ... Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric systems ... is projected to register growth at CAGR of ...
(Date:4/14/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces that its Wocket® ... York Design Awards under the category  ,Product Design – ... Awards are part of a global multi-disciplinary awards program. ... the marketplace, industry and judging panel. Winners will be ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... between a gene believed to promote long lifespan and ... The finding could help researchers create drugs that ... including atherosclerosis (clogged arteries) and Alzheimer,s disease. The ... researchers found prevents cholesterol buildup by activating a cellular ...
... can we find out about the future dangers it poses" ... Earths climate for several hundred thousand years, complete with samples ... the lab for analysis. Incredibly, this record exists, in the ... Science Foundation programme has a key role in deciphering it. ...
... The U.S. Department of Energys Office of Science ... publication, Facilities for the Future of Science: A Twenty-Year ... in deploying the scientific facilities and instruments that the ... the frontiers of science and support the Departments missions. ...
Cached Biology News:MIT links gene to cholesterol 2European lead in reading past climates from ice cores 2European lead in reading past climates from ice cores 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 2DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 3DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 4DOE publishes update of plan: 'Facilities for the Future of Science: A 20-Year Outlook' 5
MOUSE ANTI RAT KAPPA/LAMBDA:HRP Immunogen: MARK-1: Rat kappa light chains (IR202 and IR968)MARL-15: Rat lambda light chains (RH58, IR31)...
For the development of an immunoprecipitation assay to measure Chk1 kinase activity in cell lysates....
Non-Protein Peroxidase Stabilizer , 1 L...
... Gelzyme is an agarose-digesting enzyme isolated ... simple carbohydrate bonds in agarose producing ... gel. The remaining carbohydrate molecules will ... DNA isolated with Gelzyme enzyme can ...
Biology Products: